Medtronic taking market share

Quote

Anonymous

Guest
Looking at MDT, BSX and STJ numbers I'd have to conclude MDT is taking market share in CRM from both companies. So if your products are so good, why are you losing share?
 






Anonymous said:
Looking at MDT, BSX and STJ numbers I'd have to conclude MDT is taking market share in CRM from both companies. So if your products are so good, why are you losing share?
Click to expand...

Poor analysis is why. We are kicking Medtronic's ass! Shitty 3 year CRT-D devices. Medtronic is the biggest group of dillusional assholes on the planet
 


















Anonymous said:
Wall Street does the analysis and the math is quite simple even if you only have a 6th grade education. So you're either in 3rd grade or you're a complete moron!
Click to expand...

end of fiscal year bulks. they will tank while it sits and rots on the shelf and then they will have to exchange for more current devices with no up charge. wait till the next 2 quarters.
 






Your facts a laughable but at the end of the day it's giving the custumer what they want not what you think they want. The numbers don't lie, MDT's CRM revenue is more than twice any competitor, so they deserve credit for their success.
 






Anonymous said:
Your facts a laughable but at the end of the day it's giving the custumer what they want not what you think they want. The numbers don't lie, MDT's CRM revenue is more than twice any competitor, so they deserve credit for their success.
Click to expand...

Medtronic lies about their numbers. BSX is still holding onto triple digit growth in CRM. STJ and MDT will declare bankruptcy as they cannot compete against 100% reliable bulletproof BSX devices. BSX has nearly monopolized CRM world.
 






Anonymous said:
end of fiscal year bulks. they will tank while it sits and rots on the shelf and then they will have to exchange for more current devices with no up charge. wait till the next 2 quarters.
Click to expand...

From people that do not work for BSX or MDT : Try selling in bulk to Europe that cannot even pay its bills..

Medtronic continues to capture market share in a stable ICD market, resulting in worldwide sales up 2.5% ex-fx to $755 million versus the Street’s $730 million estimate. Now that all three manufacturers have reported, our market model indicates that the worldwide ICD market declined 1.2% ex-fx in CY1Q13, including a 1.2% decline in the US and down 1.2% ex-fx OUS. Once again, Medtronic increased its worldwide share to 47.6% from 46.1% y/y, with St. Jude Medical’s share decreasing to 26.9% from 27.9% y/y and Boston Scientific ceding a bit of market share to 22.1% from 22.8% y/y. In its ICD commentary, Medtronic noted that it continued to increase its lead-to-port ratio sequentially, and that it is at the highest point in several years. Further, in the US, the company’s ICD revenue was up 2.8% with volume stable and pricing improving to a 3% decline y/y, or the first quarter in several years that management has seen a sequential improvement in pricing.
 






Anonymous said:
From people that do not work for BSX or MDT : Try selling in bulk to Europe that cannot even pay its bills..

Medtronic continues to capture market share in a stable ICD market, resulting in worldwide sales up 2.5% ex-fx to $755 million versus the Street’s $730 million estimate. Now that all three manufacturers have reported, our market model indicates that the worldwide ICD market declined 1.2% ex-fx in CY1Q13, including a 1.2% decline in the US and down 1.2% ex-fx OUS. Once again, Medtronic increased its worldwide share to 47.6% from 46.1% y/y, with St. Jude Medical’s share decreasing to 26.9% from 27.9% y/y and Boston Scientific ceding a bit of market share to 22.1% from 22.8% y/y. In its ICD commentary, Medtronic noted that it continued to increase its lead-to-port ratio sequentially, and that it is at the highest point in several years. Further, in the US, the company’s ICD revenue was up 2.8% with volume stable and pricing improving to a 3% decline y/y, or the first quarter in several years that management has seen a sequential improvement in pricing.
Click to expand...

Mdt finally has a strong quarter and all the drones come out. Too funny.
 






dude you should come out of the woodwork more often and read.
you have not made a quarter in how many years..
this is not about a quarter..
the shelf loading is something that is going on for years .. it has no effect its a sustained trend per quarter for the last 10 years.

your living in a cave.

wallsteet has you flat for at best for the next 3 years.

fix your new icd
get renal going
get a valve out the door
oh and maybe someday you will hire back all the smart eng. you had and they will help you design an automated icd like all the other crm companies have.

keep thinking big battery=beat mdt and stj

go back to your cave and look at your last 10 year performance and take out a kleenex box.
 






Top Bottom
Back
Quote